Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Asthma
•
Allergic Rhinitis and Conjunctivitis
Are there best practices for integrating pollen, wildfire smoke, and AQI data into asthma/allergic rhinitis action plans?
Related Questions
Do you withhold performing skin testing for aeroallergens, foods or venoms based on poor lung function?
Is there a specific group of children that you start on AIT for prevention of asthma?
In patients with severe asthma who are candidates for biologics, do you put them on an ICS/LABA/LAMA rather than high dose ICS/LABA?
Would you stop Dupixent in an asthma patient who has good asthma control and notes improvement in loss of smell, but shows notable eosinophil elevation after 4-5 doses of the medication?
What has been your experience using gene expression profiles (GEPs) to predict treatment response in atopic dermatitis?
For adult patients on montelukast who experience vivid dreams intermittently but no other psychiatric/neuro side effects, do you permanently discontinue the medication for dreams alone or do you still have patients take it PRN if it is significantly helping to control their other allergic symptoms?
Have you experienced any issues with Alvesco inhalers getting clogged repeatedly?
Do you use skin prick testing wheal size/grade or serum IgE levels when deciding what dose of allergen immunotherapy to start a patient on?
Is there any genetic testing available for the CDHR3 receptor?
If a child 4 years of age or younger has respiratory symptoms consistent with asthma, are you diagnosing asthma or using different terminology such as bronchiolitis or reactive airway disease?
